"Hepacivirus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species.
| Descriptor ID |
D016174
|
| MeSH Number(s) |
B04.450.410 B04.820.250.475
|
| Concept/Terms |
Hepacivirus- Hepacivirus
- Hepaciviruses
- Hepatitis C-Like Viruses
- Hepatitis C Like Viruses
- Hepatitis C-Like Virus
|
Below are MeSH descriptors whose meaning is more general than "Hepacivirus".
Below are MeSH descriptors whose meaning is more specific than "Hepacivirus".
This graph shows the total number of publications written about "Hepacivirus" by people in this website by year, and whether "Hepacivirus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 1 | 4 |
| 1996 | 1 | 0 | 1 |
| 1997 | 2 | 2 | 4 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 1 | 1 |
| 2001 | 2 | 1 | 3 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 1 | 3 |
| 2004 | 2 | 1 | 3 |
| 2005 | 5 | 1 | 6 |
| 2006 | 2 | 0 | 2 |
| 2007 | 0 | 2 | 2 |
| 2008 | 3 | 0 | 3 |
| 2009 | 4 | 2 | 6 |
| 2010 | 2 | 3 | 5 |
| 2011 | 4 | 4 | 8 |
| 2012 | 4 | 5 | 9 |
| 2013 | 9 | 2 | 11 |
| 2014 | 6 | 5 | 11 |
| 2015 | 6 | 1 | 7 |
| 2016 | 7 | 1 | 8 |
| 2017 | 8 | 7 | 15 |
| 2018 | 10 | 5 | 15 |
| 2019 | 3 | 8 | 11 |
| 2020 | 2 | 5 | 7 |
| 2021 | 3 | 7 | 10 |
| 2022 | 2 | 17 | 19 |
| 2023 | 2 | 13 | 15 |
| 2024 | 0 | 4 | 4 |
| 2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepacivirus" by people in Profiles.
-
Bioactive lipid profiles as non-invasive biomarkers of advanced fibrosis in people with HIV/HCV co-infection. Metabolomics. 2025 Jul 01; 21(4):96.
-
Heavy metal exposure and hepatitis C virus infection: A cross-sectional study. J Trace Elem Med Biol. 2025 Aug; 90:127687.
-
Hepatitis C and its treatment in patients with psoriasis: a propensity-matched case-control study. Arch Dermatol Res. 2024 Aug 29; 316(8):580.
-
Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program. Gastroenterology. 2024 Dec; 167(7):1429-1445.
-
Bridging Hepatitis C Care Gaps: A Modeling Approach for Achieving the WHO's Targets in Ontario, Canada. Viruses. 2024 07 31; 16(8).
-
Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center. J Natl Compr Canc Netw. 2024 05 10; 22(2 D).
-
Sofosbuvir-velpatasvir in children 3-17 years old with hepatitis C virus infection. J Pediatr Gastroenterol Nutr. 2024 Jun; 78(6):1342-1354.
-
Hepatitis C Attributable Healthcare Costs and Mortality among Immigrants: A Population-Based Matched Cohort Study. Can J Gastroenterol Hepatol. 2024; 2024:5573068.
-
GSK-3? as a Potential Coordinator of Anabolic and Catabolic Pathways in Hepatitis C Virus Insulin Resistance. Intervirology. 2024; 67(1):6-18.
-
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline. Ann Intern Med. 2023 12; 176(12):1648-1655.